Evidence map›Paper›PMID 24945925›Full record

ArticlePLoS pathogens2014

Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes.

Tobias Schwarzmüller, Biao Ma, Ekkehard Hiller, Fabian Istel, Michael Tscherner, Sascha Brunke, Lauren Ames, Arnaud Firon, Brian Green, Vitor Cabral and 18 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 190 citations in OpenAlex.

  1. Article
  2. Article
  3. mBio · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Tn-seq screens inmSphere · 2025
    Article
  9. RapidmSphere · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. mSphere · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 14 institutions in 6 countries.

Tobias SchwarzmüllerMedical University Vienna, Max F. Perutz Laboratories, Department of Medical Biochemistry, Vienna, Austria.
Biao MaDepartment of Microbiology, Imperial College London, London, United Kingdom; Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Ekkehard HillerMolekulare Biotechnologie MBT Fraunhofer Institut für Grenzflächen- und Bioverfahrenstechnik IGB Fraunhofer, Stuttgart, Germany.
Fabian IstelMedical University Vienna, Max F. Perutz Laboratories, Department of Medical Biochemistry, Vienna, Austria.
Michael TschernerMedical University Vienna, Max F. Perutz Laboratories, Department of Medical Biochemistry, Vienna, Austria.
Sascha BrunkeDepartment Microbial Pathogenicity Mechanisms, Hans-Knoell-Institute, Jena, Germany; Friedrich Schiller University, Jena, Germany; Center for Sepsis Control and Care, CSCC, Jena University Hospital, Jena, Germany.
Lauren AmesDepartment of Microbiology, Imperial College London, London, United Kingdom; Biosciences, College of Life & Environmental Sciences, University of Exeter, Exeter, United Kingdom.
Arnaud FironInstitut Pasteur, Unité Biologie et Pathogénicité Fongiques, Département Génomes et Génétique, Paris, France; INRA, USC2019, Paris, France.
Brian GreenDepartment of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Vitor CabralInstitut Pasteur, Unité Biologie et Pathogénicité Fongiques, Département Génomes et Génétique, Paris, France; INRA, USC2019, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Cellule Pasteur, Paris, France.
Marina Marcet-HoubenBioinformatics and Genomics Programme, Centre for Genomic Regulation (CRG), Barcelona, Spain.
Ilse D JacobsenDepartment Microbial Pathogenicity Mechanisms, Hans-Knoell-Institute, Jena, Germany; Friedrich Schiller University, Jena, Germany; Center for Sepsis Control and Care, CSCC, Jena University Hospital, Jena, Germany.
Jessica QuintinUPR 9022 du CNRS, Université de Strasbourg, Equipe Fondation Recherche Médicale, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France.
Katja SeiderDepartment Microbial Pathogenicity Mechanisms, Hans-Knoell-Institute, Jena, Germany.
Ingrid FrohnerMedical University Vienna, Max F. Perutz Laboratories, Department of Medical Biochemistry, Vienna, Austria.
Walter GlaserMedical University Vienna, Max F. Perutz Laboratories, Department of Medical Biochemistry, Vienna, Austria.
Helmut JungwirthInstitut für Molekulare Biowissenschaften, Universität Graz, Graz, Austria.
Sophie Bachellier-BassiInstitut Pasteur, Unité Biologie et Pathogénicité Fongiques, Département Génomes et Génétique, Paris, France.
Murielle ChauvelInstitut Pasteur, Unité Biologie et Pathogénicité Fongiques, Département Génomes et Génétique, Paris, France.
Ute ZeidlerInstitut Pasteur, Unité Biologie et Pathogénicité Fongiques, Département Génomes et Génétique, Paris, France.
Dominique FerrandonUPR 9022 du CNRS, Université de Strasbourg, Equipe Fondation Recherche Médicale, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France.
Toni GabaldónBioinformatics and Genomics Programme, Centre for Genomic Regulation (CRG), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Bernhard HubeDepartment Microbial Pathogenicity Mechanisms, Hans-Knoell-Institute, Jena, Germany; Friedrich Schiller University, Jena, Germany; Center for Sepsis Control and Care, CSCC, Jena University Hospital, Jena, Germany.
Christophe d'EnfertInstitut Pasteur, Unité Biologie et Pathogénicité Fongiques, Département Génomes et Génétique, Paris, France; INRA, USC2019, Paris, France.
Steffen RuppMolekulare Biotechnologie MBT Fraunhofer Institut für Grenzflächen- und Bioverfahrenstechnik IGB Fraunhofer, Stuttgart, Germany.
Brendan CormackDepartment of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Ken HaynesDepartment of Microbiology, Imperial College London, London, United Kingdom; Biosciences, College of Life & Environmental Sciences, University of Exeter, Exeter, United Kingdom.
Karl KuchlerMedical University Vienna, Max F. Perutz Laboratories, Department of Medical Biochemistry, Vienna, Austria.
Max Perutz Labs · ATInstitut Pasteur · FRFraunhofer Institute for Interfacial Engineering and Biotechnology · DEJena University Hospital · DEJohns Hopkins Medicine · USLeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEUniversity of Exeter · GBCentre for Genomic Regulation · ESCentre National de la Recherche Scientifique · FRDélégation Paris 7 · FRInstitut de Biologie Moléculaire et Cellulaire · FRJohns Hopkins University · USPompeu Fabra University · ESUniversity of Graz · AT

Funding

AIDS Opportunistic Infectious: Virulence of C. glabrataR01AI046223 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CORMACK, BRENDAN · 1999 to 2014
$4.9M
AIDS Opportunistic Infections: Virulence of C. glabrataR56AI046223 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CORMACK, BRENDAN · 2009 to 2009
$187k
Austrian Science Fund FWF I 746Biotechnology and Biological Sciences Research Council BB/F005210/1Biotechnology and Biological Sciences Research Council BBS/B/10331NIAID NIH HHS R01 AI046223NIAID NIH HHS R01AI46223NIAID NIH HHS R56 AI046223
6 · The paper itself

Abstract

The opportunistic fungal pathogen Candida glabrata is a frequent cause of candidiasis, causing infections ranging from superficial to life-threatening disseminated disease. The inherent tolerance of C. glabrata to azole drugs makes this pathogen a serious clinical threat. To identify novel genes implicated in antifungal drug tolerance, we have constructed a large-scale C. glabrata deletion library consisting of 619 unique, individually bar-coded mutant strains, each lacking one specific gene, all together representing almost 12% of the genome. Functional analysis of this library in a series of phenotypic and fitness assays identified numerous genes required for growth of C. glabrata under normal or specific stress conditions, as well as a number of novel genes involved in tolerance to clinically important antifungal drugs such as azoles and echinocandins. We identified 38 deletion strains displaying strongly increased susceptibility to caspofungin, 28 of which encoding proteins that have not previously been linked to echinocandin tolerance. Our results demonstrate the potential of the C. glabrata mutant collection as a valuable resource in functional genomics studies of this important fungal pathogen of humans, and to facilitate the identification of putative novel antifungal drug target and virulence genes.

Indexed as

Antifungal AgentsAzolesBiofilmsCandida glabrataCandidiasisCaspofunginCell WallDrug Resistance, FungalEchinocandinsFungal ProteinsGene DeletionGene Knockout TechniquesGene LibraryLipopeptidesMicrobial Sensitivity TestsOsmotic PressureAntifungal AgentsAzolesCaspofunginEchinocandinsFungal ProteinsLipopeptides

Identifiers

PMID24945925
PMCPMC4063973
OpenAlexW2088309256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.